Claudio Gobbi

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis

Giulio Disanto, Christian Barro, Pascal Benkert et al. · Annals of Neurology · 2017 · 1.1K citations · Full text

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Christian Barro, Pascal Benkert, Giulio Disanto et al. · Brain · 2018 · 516 citations · Full text

Neurological Disorder, Neuro-axonal Injury, Neurological Functioning +18

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

Stéphanie Meier, Eline A.J. Willemse, Sabine Schaedelin et al. · JAMA Neurology · 2023 · 230 citations · Full text

Prodromal symptoms of multiple sclerosis in primary care

Giulio Disanto, Chiara Zecca, Sharon MacLachlan et al. · Annals of Neurology · 2018 · 159 citations